Tm6sf2^em2Yech

CRISPR-targeting introduced a G to A point mutation to produce the amino acid substitution of glutamic acid to lysine at position 167 (E167K). This mutation is analogous to the C to T variant (rs58542926-T) identified in human patients with cardiometabolic diseases. (J:314590)